Roivant Sciences $7 billion bowel drug draws major pharma interest
- ByInvesting.com-
Pharmaceutical company Roivant Sciences Ltd (NASDAQ:ROIV) has garnered interest from major pharmaceutical companies for its treatment of inflammatory bowel disease, estimated to be...